Samarth Kulkarni
PhD, University of Washington, 2006
1 story
1 quote
From an efficacy standpoint, it’s a pretty big win,
- says Samarth Kulkarni, CEO of CRISPR TherapeuticsTimetime.com/article/2026…
Earlier
With the snip of a gene, scientists hope to erase high cholesterol for life
CNNcnn.com/2026/08…Cardiovascular disease kills roughly 3.2 million Indians a year
Hindustan Timeshindustantimes.com/ht/vital…